TR BioSurgical Launches TR-ClarifEYE™ For Dog Glaucoma
16 years ago
7716 views
Posted
29th October, 2009 00h00
R ClarifEYE™ is a new, patented medical device that is implanted within the eye to recreate appropriate fluid outflow. An ongoing study in dogs has shown the implant to help maintain pressure for over one year in the majority of patients treated. The device is available to veterinarians around the world and is sold exclusively by TR BioSurgical, LLC.
About TR BioSurgical, LLC TR BioSurgical is a privately held veterinary company developing a range of biomaterials and devices for tissue repair and regenerative medicine. TR BioSurgical has specific interests in ophthalmology, dermatology, and orthopedics including cartilage repair. TR BioSurgical has one osteopromotive scaffold to market, TR Matrix™, for use in companion animals for bone repair. The company has a strong pipeline of advanced medical device technologies under development.More from
- Vetsure Named Business of the Year at 2025 SME National Business Awards
- Home of hope for Romania's dogs: The pioneering shelter doing things differently
- Pioneering new locum platform transforming veterinary landscape
- Key Stakeholders unite to advance helmet design for equine veterinary professionals
- Hallmarq hails transformational equine imaging technology
4 days ago 